scroll down

2019 China Smart Medical Industry Development Trend Prediction

Release time:

2025-03-12 09:43

Intelligent technologies, as the driving force behind smart healthcare, are continuously promoting the growth of new medical service models. In the medical field, artificial intelligence and environmental interface technologies have already had a positive impact on hospital diagnosis and treatment processes and operational models. Secondly, in order to cope with the continuously rising payment pressure, medical and health insurance models are also changing.

In addition, big data has become an important means of new drug development, accelerating the research and development of new drugs. Furthermore, patient participation, experience, and data generation supported by Internet of Things (IoT) technology are promoting the vigorous development of smart healthcare, thus better addressing the major challenges of rising medical costs and improving medical technology levels.

Nearly 80% of medical industry professionals believe that technologies such as artificial intelligence, big data, mobile medical care, and wearable devices will change the development of the medical industry in 2019.

2019Medical industry development forecast for the year:

Artificial Intelligence

In 2019, artificial intelligence (AI), robotics, cognitive technology, and precision medicine can automate many non-clinical tasks for clinicians, making medical practice more efficient. This is especially true in areas such as image diagnosis, drug discovery, tumor diagnosis and treatment, and risk analysis applications. By implementing AI platforms in specific medical service workflows, a 10-15% increase in productivity can be achieved in the next 2-3 years. AI applications play an important role in disease monitoring, decision support, and health management. In addition, 40% of healthcare providers will use machine learning and AI algorithms to improve their cybersecurity capabilities and automatically detect ransomware threats.

It is predicted that by 2021, the steady progress in the adoption of AI technology in Chinese medical institutions will directly affect 25% of business processes.

Digital Patient Experience

Driven by rising consumer expectations, 20% of healthcare providers in China will prioritize optimizing the digital patient experience (PX) as one of their top three strategic priorities before 2021.

Commercial Use of Mobile Medical Devices

With the advent of a new generation of medical devices, especially those focusing on motion, heart rate, and sleep detection. For example, smartwatches. By 2022, 20%-30% of emergency care institutions will deploy smartwatch-based applications, thereby increasing clinicians' efficiency by more than 50%.

Big Data Support

With increasing patient advocacy and favorable regulatory guidance, by 2023, real-world evidence will lead to the approval of five new drugs and ten new medical devices.

Medical Insurance Reform

Driven by the evolution of special drug Price and bundled negotiation procedures, in China, 30% of Fortune 500 companies will offer employer-direct healthcare plans in 2022, bypassing traditional medical insurance. Some emerging medical insurance institutions, whether specializing in supplementary insurance for major and chronic diseases or providing comprehensive medical insurance, focus on better user experience, more transparent insurance types, simplified sales, more direct services and payments, etc., to provide patients with more effective medical protection.

Blockchain

It is expected that by the end of 2019, 5%-10% of healthcare enterprise blockchain applications will transition from the pilot phase to commercial availability.

By 2022, the need to securely release multi-party information sharing across the healthcare and life sciences ecosystem will increase the application of blockchain in China's health industry eightfold.

"Smart healthcare", driven by data, needs to identify current pain points in the medical industry while improving medical efficiency, in order to achieve better development of the medical industry.